Immunosuppressive treatment in dialysis patients

Nephrology Dialysis Transplantation

Volumn 17, Issue SUPPL. 8, 2002, Pages 2-9

  Altieri, Paolo ^a   Sau, Giovanna ^a   Cao, Riccardo ^a   Barracca, Antonio ^a   Menneas, Amalia ^a   Micchittu, Benigna ^a   Cabiddu, Gianfranca ^a   Esposito, Paola ^a   Pani, Antonello ^a  

^a San Michele Hospital   (Italy)

Author keywords

ANCA vasculitis; Haemodialysis; Immunosuppressive therapy; MIA syndrome; Renal graft failure; SLE

Indexed keywords

AZATHIOPRINE; BETA 2 MICROGLOBULIN; C REACTIVE PROTEIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DEXAMETHASONE; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISONE; SERUM ALBUMIN; STEROID; TACROLIMUS;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BACTERIAL IMMUNITY; BACTERIAL INFECTION; BODY MASS; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GRAFT REJECTION; HEMODIALYSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; INFECTION SENSITIVITY; INFLAMMATION; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; NEUROTOXICITY; NEUTROPHIL; PHAGOCYTOSIS; PRIORITY JOURNAL; RELAPSE; RISK ASSESSMENT; SEROLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC VASCULITIS; UREMIA; AMYLOIDOSIS; MIDDLE AGED; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; REVIEW; VASCULITIS;

ADULT; AGED; AMYLOIDOSIS; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; RENAL DIALYSIS; RETROSPECTIVE STUDIES; VASCULITIS;

EID: 0036061337     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/17.suppl_8.2     Document Type: Article

References (45)

1. The immune system in uremia and during its treatment
2. Dialysis access related infection
3. Renal failure: A risk factor for methotrexate toxicity
4. Dysfunction of polymorphonuclear leukocytes in uremia
5. Initiation of hemodialysis treatment leads to improvement of T-cell activation in patients with end-stage renal disease
6. Immune dysfunction in uremia
7. Antibody level after hepatitis B vaccination in hemodialysis patients: Influence of hepatitis C virus infection
8. Effects of selenium supplementation on immune parameters in chronic uraemic patients on haemodialysis
9. T-cell activation follows Th1 rather than Th2 pattern in haemodialysis patients
10. TNF-alpha: mRNA, plasma protein levels and soluble receptors in patients on chronic hemodialysis, on CAPD and with end-stage renal failure
11. Cefonicid 'restores' the depressed activities of polymorphonuclear cells from chronic haemodialysis patients and renal transplant recipients in vitro
12. Low efficiency of active immunization against diphtheria in chronic hemodialysis patients
13. Effect of chronic human recombinant erythropoietin therapy on antibody responses to immunization in chronic hemodialysis patients
14. Biological dynamics of viral load in hemodialysis patients with hepatitis C virus
15. Effects of a parathyroidectomy on the immune system and nutritional condition in chronic dialysis patients with secondary hyperparathyroidism
16. Review of issues relating to iron and infection
17. Zinc deficiency: Prevalence and causes in hemodialysis patients and effect on cellular immune response
18. Intravenous calcitriol therapy restores reduced antigen-induced T-lymphocyte response in 1,25-(OH)2D3-deficient hemodialysis patients
19. Meltspun cellulose diacetate and polysulfone membranes have the same effect on complement activation and expression of leukocyte adhesion molecules and complement receptors
20. Impaired cellular immune function in patients with end-stage renal failure
21. Effect of the use or non use of long-term dialysis in the subsequent survival of renal transplants from living donors
22. Risk factors for peritonitis in long-term peritoneal dialysis: The network peritonitis and catheter survival studies
23. Impaired outcome of continuous peritoneal dialysis in immunosuppressed patients
24. End-stage renal disease and systemic lupus erythematosus
25. Factors associated with active systemic lupus erythematosus after end-stage renal disease
26. Persistent lupus activity in end-stage renal disease
27. Flares in lupus nephritis: Incidence, impact on renal survival and management
28. Long term outcome of Wegener's granulomatosis in patients with renal disease requiring dialysis
29. Treatment response and relapse in antineutrophil cytoplasmic antibody-associated microscopic polyangitis and glomerulonephritis
30. Intensive plasma exchange in criscentic glomerulonephritis: Help or no help?
31. Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodies
32. Outcome of renal replacement therapy in antineutrophil cytoplasmic antibody-associated systemic vasculitis
33. Survival and vasculitis activity in patients with end-stage renal disease due to Wegener's granulomatosis
34. Dialysis-related beta-2-microglobulin in amyloidosis after long-term dialysis, and the effect of renal transplantation
35. Amyloidosis associated with long-term dialysis
36. Spontaneous tendon ruptures in patients on chronic dialysis
37. Neurology and the kidney
38. Transplant nephrectomy over 20 years; factor involved in associated morbidity and mortality
39. Infections after allograft failure in patients with or without low-dose maintenance immunosuppression
40. The fate of the failed renal transplant
41. Corticosteroid withdrawal syndrome in dialysis patients
42. Reactivation of multisystemic sarcoidosis after immunosuppression withdrawal in a transplanted patient returning to chronic dialysis
43. Renal retransplant: Effect of primary allograft nephrectomy on early function, acute rejection and outcome
44. The management of the failed renal allograft
45. Severe pancytopenia caused by a single administration of low dose of methotrexate in a patient undergoing hemodialysis